Advanced glycation endproducts (AGEs) are formed by the nonenzymatic reaction of sugars with proteins. Glycation may adversely affect proteins, such as by inducing a loss of function. It has been shown that glyceraldehyde-derived AGEs (Glycer-AGEs) accumulate in the liver of patients with nonalcoholic steatohepatitis (NASH). Previously, we showed the formation of intracellular Glycer-AGEs upon exposure of hepatocytes to fructose in vitro , and identified an RNA-binding protein, heterogeneous nuclear ribonucleoprotein M (HNRNPM), as a target for glycation. However, the impact of glycated HNRNPM in NASH remains poorly understood. In this study, we examined gene expression changes caused by HNRNPM knockdown, and investigated the up- and down-regulated genes as noninvasive biomarker candidates for NASH. Microarray analysis after HNRNPM knockdown showed that the levels of 138 transcripts were increased, while those of 100 transcripts were decreased as compared with those in the control. Gene Ontology-based functional analysis showed that 14 upregulated and 9 downregulated genes were associated with the extracellular space, which may enable their detection using blood tests. Among these, six of the up- and down-regulated genes were associated with the extracellular exosome. These results suggest that the loss of HNRNPM function by glycation is reflected extracellularly. Therefore, the identified genes may serve as noninvasive biomarkers for Glycer-AGEs-related NASH.
Tappy, L. and Lê, K.A. (2010) Metabolic Effects of Fructose and the Worldwide Increase in Obesity. Physiological Reviews, 90, 23-46. https://doi.org/10.1152/physrev.00019.2009
Dekker, M.J., Su, Q., Baker, C., Rutledge, A.C. and Adeli, K. (2010) Fructose: A Highly Lipogenic Nutrient Implicated in Insulin Resistance, Hepatic Steatosis, and the Metabolic Syndrome. American Journal of Physiology. Endocrinology and Metabolism, 299, E685-E694. https://doi.org/10.1152/ajpendo.00283.2010
Vos, M.B. and Lavine, J.E. (2013) Dietary Fructose in Nonalcoholic Fatty Liver Disease. Hepatology, 57, 2525-2531. https://doi.org/10.1002/hep.26299
Attar, B.M. and Van Thiel, D.H. (2013) Current Concepts and Management Approaches in Nonalcoholic Fatty Liver Disease. The Scientific World Journal, 2013, Article ID: 481893. https://doi.org/10.1155/2013/481893
Conlon, B.A., Beasley, J.M., Aebersold, K., Jhangiani, S.S. and Wylie-Rosett, J. (2013) Nutritional Management of Insulin Resistance in Nonalcoholic Fatty Liver Disease (NAFLD). Nutrients, 5, 4093-4114. https://doi.org/10.3390/nu5104093
Matteoni, C.A., Younossi, Z.M., Gramlich, T., Boparai, N., Liu, Y.C. and McCullough, A.J. (1999) Nonalcoholic Fatty Liver Disease: A Spectrum of Clinical and Pathological Severity. Gastroenterology, 116, 1413-1419. https://doi.org/10.1016/S0016-5085(99)70506-8
Dam-Larsen, S., Franzmann, M., Andersen, I.B., et al. (2004) Long Term Prognosis of Fatty Liver: Risk of Chronic Liver Disease and Death. Gut, 53, 750-755. https://doi.org/10.1136/gut.2003.019984
Guha, I.N., Parkes, J., Roderick, P., et al. (2008) Noninvasive Markers of Fibrosis in Nonalcoholic Fatty Liver Disease: Validating the European Liver Fibrosis Panel and Exploring Simple Markers. Hepatology, 47, 455-460. https://doi.org/10.1002/hep.21984
Al-Abed, Y., Kapurniotu, A. and Bucala, R. (1999) Advanced Glycation end Products: Detection and Reversal. Methods in Enzymology, 309, 152-172.
Vlassara, H. and Palace, M.R. (2002) Diabetes and Advanced Glycation Endproducts. Journal of Internal Medicine, 251, 87-101. https://doi.org/10.1046/j.1365-2796.2002.00932.x
Glomb, M.A. and Monnier, V.M. (1995) Mechanism of Protein Modification by Glyoxal and Glycolaldehyde, Reactive Intermediates of the Maillard Reaction. Journal of Biological Chemistry, 270, 10017-10026. https://doi.org/10.1074/jbc.270.17.10017
Thornalley, P.J., Langborg, A. and Minhas, H.S. (1999) Formation of Glyoxal, Methylglyoxal and 3-Deoxyglucosone in the Glycation of Proteins by Glucose. Biochemical Journal, 344, 109-116. https://doi.org/10.1042/bj3440109
Hamelin, M., Mary, J., Vostry, M., Friguet, B. and Bakala, H. (2007) Glycation Damage Targets Glutamate Dehydrogenase in the Rat Liver Mitochondrial Matrix during Aging. The FEBS Journal, 274, 5949-5961. https://doi.org/10.1111/j.1742-4658.2007.06118.x
Kumar, P.A., Kumar, M.S. and Reddy, G.B. (2007) Effect of Glycation on Alpha-Crystallin Structure and Chaperone-Like Function. Biochemical Journal, 408, 251-258. https://doi.org/10.1042/BJ20070989
Hyogo, H., Yamagishi, S., Iwamoto, K., et al. (2007) Elevated Levels of Serum Advanced Glycation End Products in Patients with Non-Alcoholic Steatohepatitis. Journal of Gastroenterology and Hepatology, 22, 1112-1119. https://doi.org/10.1111/j.1440-1746.2007.04943.x
Takino, J., Nagamine, K., Takeuchi, M. and Hori, T. (2015) In Vitro Identification of Nonalcoholic Fatty Liver Disease-Related Protein hnRNPM. World Journal of Gastroenterology, 21, 1784-1793. https://doi.org/10.3748/wjg.v21.i6.1784
Carbon, S., Ireland, A., Mungall, C.J., et al. (2009) AmiGO: Online Access to Ontology and Annotation Data. Bioinformatics, 25, 288-289. https://doi.org/10.1093/bioinformatics/btn615
Ludwig, J., Viggiano, T.R., McGill, D.B. and Oh, B.J. (1980) Nonalcoholic Steatohepatitis: Mayo Clinic Experiences with a Hitherto Unnamed Disease. Mayo Clinic Proceedings, 55, 434-438.
Marchesini, G., Brizi, M., Bianchi, G., et al. (2001) Nonalcoholic Fatty Liver Disease: A Feature of the Metabolic Syndrome. Diabetes, 50, 1844-1850. https://doi.org/10.2337/diabetes.50.8.1844
Chitturi, S., Abeygunasekera, S., Farrell, G.C., et al. (2002) NASH and Insulin Resistance: Insulin Hypersecretion and Specific Association with the Insulin Resistance Syndrome. Hepatology, 35, 373-379. https://doi.org/10.1053/jhep.2002.30692
Marchesini, G., Bugianesi, E., Forlani, G., et al. (2003) Nonalcoholic Fatty Liver, Steatohepatitis, and the Metabolic Syndrome. Hepatology, 37, 917-923. https://doi.org/10.1053/jhep.2003.50161
Sato, T., Wu, X., Shimogaito, N., Takino, J., Yamagishi, S. and Takeuchi, M. (2009) Effects of High-AGE Beverage on RAGE and VEGF Expressions in the Liver and Kidneys. European Journal of Nutrition, 48, 6-11. https://doi.org/10.1007/s00394-008-0753-4
Ahmed, M.U., Dunn, J.A., Walla, M.D., Thorpe, S.R. and Baynes, J.W. (1988) Oxidative Degradation of Glucose Adducts to Protein. Formation of 3-(N Epsilon-Lysino)-Lactic Acid from Model Compounds and Glycated Proteins. The Journal of Biological Chemistry, 263, 8816-8821.
Iijima, K., Murata, M., Takahara, H., Irie, S. and Fujimoto, D. (2000) Identification of NΩ-carboxymethylarginine as a Novel Acid-Labile Advanced Glycation End Product in Collagen. Biochemical Journal, 347, 23-27. https://doi.org/10.1042/bj3470023
Datar, K.V., Dreyfuss, G. and Swanson, M.S. (1993) The Human HNRNPM Proteins: Identification of a Methionine/Arginine-Rich Repeat Motif in Ribonucleoproteins. Nucleic Acids Research, 21, 439-446. https://doi.org/10.1093/nar/21.3.439
Kim, H., Jeong, E., Lee, S.W. and Han, K. (2003) Computational Analysis of Hydrogen Bonds in Protein-RNA Complexes for Interaction Patterns. FEBS Letters, 552, 231-239. https://doi.org/10.1016/S0014-5793(03)00930-X
Lejeune, D., Delsaux, N., Charloteaux, B., Thomas, A. and Brasseur, R. (2005) Protein-Nucleic Acid Recognition: Statistical Analysis of Atomic Interactions and Influence of DNA Structure. Proteins: Structure, Function, and Bioinformatics, 61, 258-271. https://doi.org/10.1002/prot.20607
Ellis, J.J., Broom, M. and Jones, S. (2007) Protein-RNA Interactions: Structural Analysis and Functional Classes. Proteins: Structure, Function, and Bioinformatics, 66, 903-911. https://doi.org/10.1002/prot.21211
Ciriello, G., Gallina, C. and Guerra, C. (2010) Analysis of Interactions between Ribosomal Proteins and RNA Structural Motifs. BMC Bioinformatics, 11, S41. https://doi.org/10.1186/1471-2105-11-S1-S41
Sookoian, S., Gianotti, T.F., Rosselli, M.S., Burgueno, A.L., Castaño, G.O. and Pirola, C.J. (2011) Liver Transcriptional Profile of Atherosclerosis-Related Genes in Human Nonalcoholic Fatty Liver Disease. Atherosclerosis, 218, 378-385. https://doi.org/10.1016/j.atherosclerosis.2011.05.014